AMG National Trust Bank Has $7.64 Million Holdings in CVS Health Corporation $CVS

AMG National Trust Bank lifted its holdings in CVS Health Corporation (NYSE:CVS) by 1.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 110,770 shares of the pharmacy operator’s stock after acquiring an additional 1,258 shares during the period. AMG National Trust Bank’s holdings in CVS Health were worth $7,641,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of CVS. Avion Wealth grew its stake in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in CVS Health during the second quarter worth about $30,000. Bell Investment Advisors Inc grew its stake in CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 248 shares in the last quarter. Roxbury Financial LLC grew its stake in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares in the last quarter. Finally, ORG Partners LLC grew its stake in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 377 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on CVS. Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. The Goldman Sachs Group began coverage on shares of CVS Health in a research note on Tuesday, October 14th. They set a “buy” rating and a $91.00 price objective on the stock. Bernstein Bank reduced their price objective on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Wolfe Research increased their target price on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Monday, September 22nd. Finally, Mizuho increased their target price on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $86.33.

Insider Transactions at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.22% of the company’s stock.

CVS Health Stock Down 4.8%

CVS stock opened at $76.70 on Friday. The stock has a market capitalization of $97.28 billion, a P/E ratio of 201.84, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The firm has a 50-day moving average price of $76.35 and a 200-day moving average price of $68.98.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.